Anemia
Anemia is a condition in which the body does not have enough healthy red blood cells or hemoglobin to adequately transport oxygen throughout the body. Because oxygen is essential for cellular energy production, organ function, and tissue repair, anemia can affect nearly every system and lead to symptoms ranging from mild fatigue to serious medical complications.
Anemia is not a disease itself, but rather a condition that can result from a variety of underlying causes, including iron deficiency, vitamin B12 or folate deficiency, chronic disease, blood loss, inherited blood disorders, kidney disease, cancer treatments, and autoimmune conditions. Depending on the cause and severity, symptoms may include fatigue, weakness, shortness of breath, dizziness, headaches, pale skin, difficulty concentrating, and reduced exercise tolerance.
While many cases can be effectively managed by addressing the underlying cause, severe anemia can become a medical emergency when oxygen delivery to vital organs is significantly compromised. In certain situations involving exceptional blood loss, Hyperbaric Oxygen Therapy (HBOT) is recognized as an FDA-approved treatment that can help support oxygen delivery while definitive medical treatment is being provided.
Understanding Anemia
Red blood cells contain hemoglobin, an iron-rich protein responsible for carrying oxygen from the lungs to the body’s tissues. When red blood cell levels or hemoglobin levels fall below normal, the amount of oxygen available to cells decreases. As a result, organs and tissues may struggle to produce the energy needed for normal function.
The effects of anemia can extend throughout the body. The brain may receive less oxygen, contributing to fatigue, dizziness, headaches, and difficulty concentrating. Muscles may tire more quickly during physical activity, while the heart often works harder to compensate for reduced oxygen-carrying capacity by increasing heart rate and cardiac output. In severe cases, prolonged oxygen deficiency can place significant strain on the cardiovascular system and other vital organs.
Because anemia can arise from many different causes, proper evaluation is essential. Identifying whether anemia is related to nutritional deficiencies, blood loss, chronic illness, inflammation, medication use, digestive disorders, or other underlying conditions helps guide the most appropriate treatment strategy and long-term management plan.
Extivita Therapies for Anemia
Hyperbaric Oxygen Therapy
Neurofeedback Therapy
Nutritional IV Therapy
Pulsed Electromagnetic Field Therapy (PEMF)
Food Sensitivity Testing
Hyperbaric Oxygen Therapy (HBOT) for Anemia
Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% medical-grade oxygen inside a pressurized chamber, typically at pressures between 2.0 and 3.0 atmospheres absolute (ATA). Under these conditions, oxygen dissolves directly into the plasma portion of the blood at concentrations significantly higher than can be achieved under normal atmospheric conditions.
Under normal circumstances, most oxygen is transported throughout the body by hemoglobin contained within red blood cells. In patients with anemia, especially severe anemia caused by exceptional blood loss, the body’s ability to carry oxygen can become significantly compromised. Hyperbaric Oxygen Therapy provides a unique solution by dramatically increasing the amount of oxygen dissolved directly into the plasma, allowing oxygen to reach tissues even when red blood cell levels are critically reduced.
HBOT is recognized by both the U.S. Food and Drug Administration (FDA) and the Undersea & Hyperbaric Medical Society (UHMS) as an approved treatment for severe anemia associated with exceptional blood loss, particularly when blood transfusion is not possible, contraindicated, or insufficient to meet the body’s oxygen demands.
HBOT research shows how individuals with severe anemia may benefit from:
Increased Oxygen Delivery Independent of Hemoglobin
In healthy individuals, hemoglobin is responsible for transporting nearly all oxygen throughout the body. HBOT significantly increases the amount of oxygen dissolved directly into blood plasma, allowing oxygen to bypass the normal dependence on red blood cells and continue reaching vital organs and tissues. This unique mechanism is the foundation of HBOT’s role in the treatment of severe anemia.
Temporary Support During Critical Blood Loss
In cases of severe hemorrhage or exceptional blood loss, oxygen delivery to tissues can become critically impaired. HBOT can temporarily increase plasma oxygen concentrations to levels capable of supporting basic tissue oxygen requirements while definitive treatment is being provided and the body works to restore normal red blood cell levels.
Protection of Vital Organs from Oxygen Deficiency
The brain, heart, kidneys, and other organs are highly dependent on a continuous oxygen supply. When severe anemia reduces oxygen-carrying capacity, these organs may be at increased risk for injury. By increasing oxygen availability throughout the body, HBOT may help support tissue viability and reduce the effects of oxygen deprivation during periods of critically low hemoglobin levels.
Support for Patients Unable to Receive Blood Transfusions
Some patients may be unable to receive blood transfusions due to medical contraindications, limited blood availability, personal preferences, or religious beliefs. HBOT has been successfully utilized as a supportive therapy in these situations, helping maintain oxygen delivery while alternative treatment strategies are implemented and the body produces new red blood cells.
Enhanced Oxygen Diffusion to Oxygen-Starved Tissues
The elevated oxygen levels achieved during HBOT create a greater diffusion gradient, allowing oxygen to penetrate deeper into tissues that may be receiving inadequate oxygen due to reduced blood oxygen-carrying capacity. This can be particularly important during periods of severe anemia when normal oxygen transport mechanisms are compromised.
Support for Cellular Energy Production
Every cell in the body relies on oxygen to generate energy through aerobic metabolism. By improving oxygen availability, HBOT helps support cellular energy production and may assist tissues in maintaining normal metabolic function during periods of reduced hemoglobin availability.
Bridge Therapy While Underlying Causes Are Addressed
HBOT does not replace treatment of the underlying cause of anemia. Instead, it serves as a valuable supportive therapy that can help maintain oxygen delivery while physicians address the source of blood loss, correct nutritional deficiencies, treat underlying medical conditions, or implement other appropriate interventions.
Established Clinical Use and Evidence Base
The use of Hyperbaric Oxygen Therapy for severe anemia is supported by decades of clinical experience, published case reports, treatment guidelines, and recognition by both the FDA and UHMS. It remains one of the few situations in medicine where oxygen delivered through plasma alone can temporarily sustain tissue oxygenation despite critically low hemoglobin levels.
A Unique FDA-Approved Application of Hyperbaric Oxygen Therapy:
Unlike many conditions for which HBOT is being actively researched, severe anemia resulting from exceptional blood loss is an established FDA-approved indication. The therapy’s ability to deliver oxygen directly through plasma provides a unique and scientifically supported approach for helping maintain tissue oxygenation when the body’s normal oxygen transport system is significantly impaired.
Neurofeedback Therapy for Anemia
When nutrients are delivered intravenously, nearly 100% of those nutrients are immediately available to the body’s cells and tissues via the bloodstream. This bypasses the digestive system, allowing for faster and more complete absorption than oral supplementation.
In individuals with anemia, deficiencies in iron, B vitamins, and other key nutrients impair red blood cell production and oxygen delivery throughout the body. IV therapy provides targeted, high-dose delivery of these essential nutrients, supporting hemoglobin production, improving oxygen transport, and helping restore energy levels more efficiently than oral approaches alone.
Neurofeedback Benefits for Anemia:
Improved Cognitive Function and Mental Clarity
Anemia commonly presents with brain fog, slowed processing speed, and difficulty concentrating due to reduced oxygen delivery to neural tissue. Neurofeedback helps optimize brainwave patterns—particularly alpha and sensorimotor rhythm (SMR)—to enhance attention, working memory, and processing efficiency. Patients often experience clearer thinking and improved ability to focus on daily tasks.
Fatigue Reduction and Energy Regulation
Chronic fatigue is one of the most prevalent and limiting symptoms of anemia. Neurofeedback helps regulate cortical activation levels by reducing excessive slow-wave (theta) activity associated with mental fatigue and low energy states. By promoting more efficient neural signaling, patients may experience improved mental stamina and reduced cognitive exhaustion throughout the day.
Mood Stability and Reduced Irritability
Anemia is often associated with mood changes, including irritability, low motivation, and depressive symptoms. These effects are partially driven by decreased oxygen delivery and altered neurotransmitter activity. Neurofeedback can help stabilize brainwave patterns in the prefrontal cortex and limbic regions, supporting improved emotional regulation, resilience, and overall mood balance.
Support for Sleep Quality and Recovery
Fatigue in anemia is often compounded by poor sleep quality or non-restorative sleep. Neurofeedback can train the brain to transition more effectively into restorative slow-wave sleep and maintain stable sleep architecture. Improved sleep quality enhances overall energy levels, cognitive performance, and recovery.
IV Therapy for Anemia
When nutrients are delivered intravenously, nearly 100% of those nutrients are immediately available to the body’s cells and tissues via the bloodstream. This bypasses the digestive system, allowing for faster and more complete absorption than oral supplementation.
In individuals with anemia, deficiencies in iron, B vitamins, and other key nutrients impair red blood cell production and oxygen delivery throughout the body. IV therapy provides targeted, high-dose delivery of these essential nutrients, supporting hemoglobin production, improving oxygen transport, and helping restore energy levels more efficiently than oral approaches alone.
How IV Therapy Supports Anemia
Red Blood Cell Production and Hemoglobin Support
Anemia is defined by reduced hemoglobin levels and impaired oxygen-carrying capacity. IV therapy can deliver key nutrients such as iron, vitamin B12, folate, and B-complex vitamins directly into circulation, supporting erythropoiesis (red blood cell production) in bone marrow. This targeted delivery helps restore hemoglobin levels more rapidly, particularly in individuals with moderate to severe deficiencies or impaired absorption.
Improved Oxygen Delivery and Energy Levels
Reduced hemoglobin limits oxygen transport to tissues, leading to fatigue, weakness, and decreased physical and cognitive performance. By replenishing critical nutrients required for red blood cell function, IV therapy helps improve oxygen delivery throughout the body. Patients often experience increased energy, reduced fatigue, and improved overall stamina as oxygenation improves.
Correction of Nutrient Deficiencies
Many cases of anemia are driven by deficiencies in iron, vitamin B12, folate, or other micronutrients. Oral supplementation can be limited by poor absorption, gastrointestinal side effects, or compliance challenges. IV therapy bypasses these barriers, allowing for precise correction of deficiencies with therapeutic dosing tailored to the patient’s needs.
Quickest, most effective way to
supply our cells with the nutrients
they need
Customized nutrient add-on
to target your specific
health concerns
Supports neurotransmitter balance, reduces inflammation, and restores cellular energy
Key IV Recommendations for Anemia
Myers’ Cocktail IV
Components: B-complex vitamins, Vitamin C, Magnesium, and Calcium
- B‑complex vitamins (especially B12 and folate) support DNA synthesis and proper red blood cell formation.
-
Vitamin C enhances iron absorption and helps improve iron utilization in the body.
- Supports overall energy production and helps reduce fatigue commonly associated with anemia.
NAD+ Trio IV
Components: NAD+, Glutathione, and Magnesium
-
NAD+ supports mitochondrial function, helping improve energy levels in patients experiencing severe fatigue.
- Glutathione reduces oxidative stress, which can contribute to red blood cell damage and impaired function.
Pulsed Electromagnetic Field (PEMF) Therapy for Anemia
PEMF Therapy uses low-frequency electromagnetic waves to stimulate cellular function, improve circulation, and support the body’s natural healing processes. In anemia, where reduced hemoglobin limits oxygen delivery to tissues, PEMF can help optimize microcirculation, enhance cellular energy production, and support the physiological systems involved in red blood cell function and recovery.
By improving blood flow, cellular signaling, and mitochondrial efficiency, PEMF provides a supportive, non-invasive adjunct to therapies aimed at restoring oxygen transport and reducing fatigue associated with anemia.
How PEMF Therapy Supports Anemia
Improved Circulation and Oxygen Delivery
Anemia reduces the blood’s capacity to carry oxygen, placing greater importance on efficient circulation. PEMF enhances microcirculation and blood flow, helping optimize oxygen delivery to tissues despite reduced hemoglobin levels. Improved perfusion supports better tissue oxygenation, energy levels, and overall function.
Cellular Energy and Mitochondrial Support
Fatigue in anemia is driven not only by reduced oxygen supply but also by impaired cellular energy production. PEMF has been shown to support mitochondrial activity and ATP production, helping cells utilize available oxygen more efficiently. This contributes to improved energy levels, reduced fatigue, and better overall endurance.
Support for Red Blood Cell Function and Longevity
Oxidative stress and inflammation can impair red blood cell integrity and lifespan. PEMF helps modulate cellular stress responses and may support healthier blood cell function by improving membrane stability and reducing oxidative burden, contributing to more efficient oxygen transport.
Reduction in Fatigue and Physical Symptoms
Fatigue, weakness, and reduced stamina are hallmark symptoms of anemia. By improving circulation, enhancing cellular energy production, and supporting overall physiological efficiency, PEMF can help reduce the severity of these symptoms and improve day-to-day functional capacity.
Food Sensitivty Testing for Anemia
Food sensitivity testing identifies specific foods that may be triggering immune responses or interfering with proper nutrient absorption in your body. Unlike immediate food allergies, which cause rapid reactions, food sensitivities can create low-grade inflammation and digestive disruption that persists for days.
In individuals with anemia, these reactions can impair the body’s ability to absorb critical nutrients such as iron, vitamin B12, and folate—nutrients essential for red blood cell production and oxygen transport. Over time, this can contribute to persistent deficiencies, fatigue, and delayed recovery.
How Food Sensitivity Testing Supports Anemia:
Identifies Barriers to Nutrient Absorption
Certain food sensitivities can irritate the digestive tract and reduce the body’s ability to properly absorb iron and essential vitamins. By identifying and removing these trigger foods, patients can improve nutrient uptake and support more effective correction of anemia.
Supports Gut Health and Iron Utilization
A healthy gut is essential for absorbing and utilizing nutrients needed for red blood cell production. Food sensitivities can contribute to inflammation and increased intestinal permeability, which disrupts this process. Eliminating reactive foods helps restore gut integrity, allowing the body to better absorb iron, B12, and folate.
Reduces Inflammation That Can Worsen Anemia
Chronic, low-grade inflammation can interfere with iron metabolism and red blood cell production. By identifying foods that contribute to inflammation, patients can reduce this burden and create a more favorable environment for hematologic recovery.
Read to Begin Your Journey to Recovery?
Schedule a Free Wellness Visit to explore a personalized plan designed around your goals and concerns.
Schedule Your Free Wellness Visit →
References:
- Abdelwahab, O., Abdelaziz, A., Diab, S., Khazragy, A., Elboraay, T., Fayad, T., Diab, R.A., & Negida, A. (2024). Efficacy of different routes of vitamin B12 supplementation for the treatment of patients with vitamin B12 deficiency: A systematic review and network meta-analysis. Irish Journal of Medical Science, 193(3), 1621–1639. https://doi.org/10.1007/s11845-023-03602-4
- Camaschella, C., Pagani, A., Silvestri, L., & Nai, A. (2022). The mutual crosstalk between iron and erythropoiesis. International Journal of Hematology. https://doi.org/10.1007/s12185-022-03384-y
- DeLoughery, T. G., Jackson, C. S., Ko, C. W., & Rockey, D. C. (2024). AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22(8), 1575–1583. https://doi.org/10.1016/j.cgh.2024.03.046
- Johnson‑Arbor, K., & Cooper, J.S. (2025). Hyperbaric therapy in blood loss anemia. StatPearls Publishing.
- Kolarš, B., Mijatović Jovin, V., Živanović, N., Minaković, I., Gvozdenović, N., Dickov Kokeza, I., & Lesjak, M. (2025). Iron deficiency and iron deficiency anemia: A comprehensive overview of established and emerging concepts. Pharmaceuticals, 18(8), 1104. https://doi.org/10.3390/ph18081104
- Merck Manual Professional Edition. (2025). Iron deficiency anemia.
- Narla, A., & Mohandas, N. (2019). Red cells, iron, and erythropoiesis. Blood, 134(18), 1484–1485. https://doi.org/10.1182/blood.2019003022
- Sandhu, A.H., & Radhakrishnan, A. (2025). Gut biome-mediated barriers to nutrient absorption: Investigating the impact of dysbiosis. Microbiology Research, 16(11), 241. https://doi.org/10.3390/microbiolres16110241
- Soni, R., Verma, D., Chopra, R., Singh, V., & Goswami, D. (2025). Demystifying intricate factors of nutritional anemia beyond iron deficiency: A narrative review. Clinical Nutrition ESPEN, 69, 745–764.
- Stephenson, M.C., Krishna, L., Selvan, R.M.P., Tai, Y.K., Wong, C.J.K., Yin, J.N., et al. (2022). Magnetic field therapy enhances muscle mitochondrial bioenergetics and attenuates systemic metabolic disruption: A randomized-controlled pilot trial. Journal of Orthopaedic Translation, 35, 99–112. https://doi.org/10.1016/j.jot.2022.09.011
- Undersea & Hyperbaric Medical Society (UHMS). (2024). Hyperbaric oxygen therapy indications: Severe anemia.
- Van Doren, L., & Auerbach, M. (2023). IV iron formulations and use in adults. Hematology, American Society of Hematology Education Program, 2023(1), 622–629. https://doi.org/10.1182/hematology.2023000495
- Van Meter, K.W. (2024). Hyperbaric oxygen therapy in the resuscitative management of severe anemia. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1408816
- Zavadskis, S., Gasser, A.S., Karas, M., Kostrebic, S., Flatscher, J., Vaglio-Garro, A., et al. (2026). Interaction of pulsed low-frequency electromagnetic fields with mitochondria. Scientific Reports, 16, 6681. https://doi.org/10.1038/s41598-026-37527-6